The physical world presents a very different landscape at the nanometer scale. Physical phenomena such as inertia and gravity vanish from view; instead the interactions of matter and energy are dominated by other phenomena like wave-particle duality, uncertainty, and quantum electrodynamics. Nanotechnology is the engineering of functional systems at this scale, where the axioms that govern material and device design differ dramatically from those found at the macroscale level. More precisely, "nanotechnology" typically encompasses both the miniaturization of existing technologies to the nanoscale, and the discipline of engineering molecular-scale systems from the bottom up, producing constructs with fundamentally new qualities that revolutionize human engineering, from materials and manufacturing, electronics, and information technology, to medicine, biotechnology, energy, and even security. The array of goals and applications in nanotechnology intersects with an equally wide array of techniques and materials with their own emergent properties in the field. One such branch is concerned with the re-engineering of biological mechanisms, systems, and molecules in new forms with new utilities, broadly termed bio-nanotechnology.
Introduction
The physical world presents a very different landscape at the nanometer scale. Physical phenomena such as inertia and gravity vanish from view; instead the interactions of matter and energy are dominated by other phenomena like wave-particle duality, uncertainty, and quantum electrodynamics. Nanotechnology is the engineering of functional systems at this scale, where the axioms that govern material and device design differ dramatically from those found at the macroscale level. More precisely, "nanotechnology" typically encompasses both the miniaturization of existing technologies to the nanoscale, and the discipline of engineering molecular-scale systems from the bottom up, producing constructs with fundamentally new qualities that revolutionize human engineering, from materials and manufacturing, electronics, and information technology, to medicine, biotechnology, energy, and even security. The array of goals and applications in nanotechnology intersects with an equally wide array of techniques and materials with their own emergent properties in the field. One such branch is concerned with the re-engineering of biological mechanisms, systems, and molecules in new forms with new utilities, broadly termed bio-nanotechnology.
The field of nanotechnology taking advantage of nucleic acids has its origins in the work of Nadrian Seeman and coworkers who have, over the past 30 years, spearheaded the development of DNA nano-object fabrication utilizing DNA self-assembly [1] [2] [3] [4] [5] [6] . Briefly, DNA nanotechnology uses the nature of DNA complementarity for the construction of DNA tiles with discrete secondary structure by canonical WatsonCrick interactions (G-C and A-T base pairing), using a relatively small number of structural rules fundamentally based on Holliday junction motifs. The use of these rules has resulted in the engineering and characterization of numerous DNA 3D nanoscaffolds with different connectiviities [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] and the ability for some of them to promote targeted delivery by functioning as DNA nano-capsules [19] [20] [21] or DNA nano-carriers for other functionialities [22] . Another powerful technique called DNA "origami", developed by Paul Rothemund [23] , has been extended from its original scope for designing different 2D DNA shapes [24] and functional templates [25] [26] [27] [28] to the creation of 3D objects such as a pyramidal tetrahedron [29] , a functional nano-box [30, 31] and a nanorobot [32] , or shapes [33] relying on tensegrity [34] (structural integrity maintained by opposed tension in internal components) or helix bundles [35] . Similarly, Chad Mirkin and colleagues have done significant work using DNA oligonucleotides to form nanoparticle (NP) probes [36] by modifying colloidal nanoparticles with oligonucleotides which, upon the introduction of a complementary sequence, allow the self-assembly of nanoparticles into two-and three-dimensional architectures [37, 38] .
Engineered RNA Nanodesigns for Applications in RNA Nanotechnology applications of RNA nanotechnology, is exemplified by currently over 20 different RNA-based therapeutics in clinical testing [60] . The majority of these are now in phase I or II clinical trials,
with none yet reaching phase III. It is important to note that the first efforts in applying the breakthroughs in RNA research discussed above were met with middling success that was far outweighed by the hype that surrounded it, however, the application of RNA has still progressed extremely rapidly [61] .
This fact, taken together with the burgeoning of multiple startup companies makes the development of novel RNA therapeutics very real. RNA nanotechnology is uniquely able to harness the variety of catalytic functions RNA performs as well as organize these functions with a precise stoichiometry and orientation in 3D space.
Compared to proteins and some synthetic materials, RNA nanomedicine offers the potential for high specificity and low toxicity treatments of many diseases through the utilization of naturally occurring mechanisms [58, 60, 62] such as RNAi.
Synthetically designed RNAs have the potential to form dynamic regulatory platforms for metabolic pathways and other natural systems [63] . They also can specifically recognize folded RNAs [64] and small molecules [65] , regulate pathway expression [66, 67] , and contribute to programmable genetic circuitry [68] [69] [70] .
The basis of RNA nanotechnology
The breadth of functionality in biologically occurring RNAs provides a very powerful foundation for the bottom up design of nanodevices in the form of various structural motifs and functional elements which operate in native biological systems, and can be derived from X-ray and NMR structures of natural molecules [59, [71] [72] [73] [74] [75] [76] [77] [78] . This repertoire of natural RNA motifs is augmented by new motifs with novel binding selectivities or enzymatic capabilities, obtained by in vitro selection, also called Systematic Evolution of Ligands by Exponential Enrichment (SELEX) [79, 80] , in which randomized pools of oligonucleiotides are iteratively selected, amplified, and mutated to enrich highaffinity binding to targets; as well as through rational design from biochemical principles [74, 77, 81] . Finally, all of these motifs can then be categorized into publicly available libraries for use in RNA nanotechnology.
The foundations of RNA nanobiology draw from several areas (see Figure 1 ) related to the understanding of RNA structure and function that reinforce each other and together can significantly speed-up the design process for determining the sequences needed for the correct folding and assembly of RNA nanoobjects. In many cases the RNA design process essentially works in reverse of standard RNA structure/function determination practices. Normally RNA sequences are provided and the issue at hand is to determine the RNA secondary structure and ultimately Presently, nearly all of the nucleic acid based polyhedral nano-scaffolds designed and tested in vitro employ DNA molecules as building blocks and have diameters greater than 15 nm [33, 39, 40] . Although these DNA nano-structures have demonstrated the potential to develop programmable scaffolds for nanotechnological applications [41] , DNA biopolymers are not always able to mimic the diverse biological functions of its structural counterpart -RNA. RNA may also serve as an attractive biomaterial for a variety of nanotechnological applications, because of its unique structural, chemical, and biophysical properties which have some advantages compared to those of DNA [42, 43] . Both DNA and RNA have intrinsic, manipulable features at the nanoscale and form systems with limited primary structures of four basic components. However, the presence of the 2'-OH group in RNA has a dramatic effect on its properties. Due to base stacking properties and the fixed C3'-endo sugar associated A-form helical structure, double stranded RNA offers improved thermal stability versus a DNA helix; this, combined with the ability of RNAs to form non-canonical base pairings, leads to the natural library of diverse structural motifs which in turn create a wide array of complex structures, many of which possess functional properties similar to proteins while retaining the simplicity of nucleotide primary structure [44] [45] [46] . predict the function in synthetic macromolecule design [43] .
Furthermore, RNA constructs have the potential to be integrated into native cellular machinery and thus, take advantage of expression within cells [47] [48] [49] . It should also be noted, however, that a diverse assortment of modified nucleotides, both natural and artificial, exist, and are particularly suited for integration with RNA structures, and present their own further challenges and opportunities. Natural modified nucleotides, such as pseudouridines, may simultaneously provide another tool for designers while also increasing a system's complexity and thus the difficulty of application. Similarly, synthetic nucleic acids with promising properties, for example locked nucleic acids (LNAs), expand the library of possible base components and possible functions in nucleic acid nanodesign.
RNA was first characterized as a messenger in transcription in the 1940s and 50s [50] [51] [52] and its first function described in the 1960s [53, 54] . It was twenty years later that the work of Tom Cech and Sidney Altman demonstrated the self-splicing of a ribosomal RNA precursor, and revolutionized the study of RNA [55, 56] . Where before catalytic potential was thought reserved exclusively for proteins, this discovery immediately initiated a cascade of other multitasking functions assigned to RNA. The later discovery by Andrew Fire and Craig Mello, regarding the ability of RNA to selectively control gene expression in animals through the process of RNA interference (RNAi) [57] , has cemented the place of RNA as an extremely important molecule for study with far reaching applications in medicine, science, and engineering. In particular, the capacity to understand and create customizable, functional RNAs has led to the genesis of a Engineered RNA Nanodesigns for Applications in RNA Nanotechnology
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For the purposes of design, all modular components of RNA nanotechnology can be divided into two semantic classes: functional and tectonic units ( Figure 2 ). However, these classes are not necessarily mutually exclusive.
The first class represents RNA based functionalities with desirable chemical or biological activity including ribozymes [82, 83] , aptamers [84] [85] [86] , riboswitches [87, 88] , and RNAi inducing agents (e.g. short interfering RNA (siRNA), micro RNA (miRNA), etc) [89, 92] as well as functionalities with a the three-dimensional structure of the RNA. This is frequently accomplished by X-ray crystallography or nuclear magnetic resonance, though RNA secondary structural information, whether derived from experimental techniques or computational algorithms, is extremely helpful in determining the 3D structure of an RNA. Once characterized, the three-dimensional structure then provides a platform from which function can be determined and understood. Conversely, RNA nanodesign first decides upon the three-dimensional shape and position of scaffold structures and functional elements and only then is the secondary structure (or lack thereof), and ultimately primary structure determined. sequence are necessary to ensure that 3D hydrogen bonding intrinsic to the tertiary structure is uninterrupted, and may limit the potential modifications of any given nanostructure. A secondary structure is then extrapolated from the 3D model and used to rationally design the set of primary sequences for the monomers involved in the formation of the particle.
These structures can be characterized through biochemical experimentation and visualization techniques for the purposes of tuning designs or investigating structural systems with limited initial data.
non-RNA nature (proteins, small targeting molecules, gold NP, etc) [93] [94] [95] [96] , discussed in detail in Functionalization and Modification, below. The second class encompasses tectonic units that can be split into structural motifs and interacting motifs possessing discrete secondary and tertiary structures which can be combined to rationally produce self-assembling nanoparticles with predictable, multi-dimensional structures in vivo or in vitro. Some examples of structural motifs are double-stranded RNA helices, C-loops [72] (which increase the helical twists), kink-turns [97] , right angle motifs [78] , tRNA motifs [98] (the latter three bends within an oligonucleotide strand); as well as three [76, 99] , four [100, 101] , and five way junctions [100] . Examples of interacting motifs are tetraloopreceptors [74] (an interaction between a four-base hairpin "tetra-loop" motif and a "receptor" structured internal loop motif), kissing loops [102, 103] sequence which assembles into a regular extended structure reminiscent of extended lattices in DNA nanotechnology [122] . Our knowledge and understanding of RNA is expanding continuously, and ongoing research will continue to reveal other structures which will feed back into the motif libraries at our disposal (see Computational tools and methods).
In addition to the efficiency of using pre-existing motifs, the RNA architectonics strategy has numerous advantages in structural control and stability. However, oligonucleotides used in architectonics are often quite long and may require complex and junctions with specified angle ranges between emanating helical stubs by which other helices can connect.
3D Modeling tools.
In addition to databases, there are numerous design tools that help arrange, join, and model RNA structural elements in a 3D workspace [124, 126, [130] [131] [132] . There are numerous general purpose molecular modeling packages, such as Chimera [133] , pyMol [134] , and the Accelrys (http://accelrys.com/) suite. Each of these programs provides its own unique capabilities which may have uses for RNA nanodesign, however, they are typically incapable of specifically addressing the demands of RNA nanodesign. As an illustrative example of this, Chimera is capable of altering the geometry of a visualized nanoparticle by rotating a base pair on its axis, however, it does so unphysically; it does not "understand" RNA mechanics, and so the design must then be imported into a different program before any nanoparticle designed using this method could form.
Alternatively, tools specifically designed for use with RNA and in nanodesign exist, which can simplify this process. One such tool is NanoTiler, which can generate defined nanoparticles from tectonic units found in the RNAJunction database or elsewhere
These units can be connected by "standard" A form RNA helices of varying lengths [124, 126] . Nanotiler allows the topological specification of desired structures and the sequence constraints necessary to conserve desirable tertiary interactions. It can also create do novo structures to fit design goals, and apply translation, bending, and twisting deformations to maximize "goodness of fit" in accordance with natural RNA dynamics.
Moreover, in conjunction with a sequence generator, the program has the capacity to create sequence sets derived from the initial 3D atomic models which have demonstrated a high probability to self-assemble into desired constructs under experimental conditions. NanoTiler was used to design the nanocube and nanoring shown as examples in Figures 1 and 2 , and the cube corner elements are an example of a motif created de novo when no natural motif with the desired property could be found. The structures generated by NanoTiler can then be imported into an associated sequence optimization program which can generate sequences that were used in the self-assembly experiments.
Another modeling program is RNA2D3D [131] ; while NanoTiler represents a class of tools for the construction of de novo structures, RNA2D3D allows for rapid 3D visualization of supramolecular structures from primary and secondary structure information, and provides tools to subsequently adjust the structure, eliminate steric clashes, and optimize its energy and dynamics. Given the secondary structure pairing information and the primary sequence, the program transforms the paired regions of a secondary structure into idealized helices, and then integrates helical geometry with adjacent loops, automatically An example of this methodology are the RNA nanocubes [104] ; 3D models were generated using Nanotiler (see Computational tools and methods), and the sequence optimized via randomization and Monte Carlo optimization algorithms.
Designs of single-strand assemblies have been successfully used to generate trimers [125] , tetramers [107, 123] , hexamers [104, 106] , octamers [105] , decamers [104] that can be functionalized with aptamers, siRNAs, or non nucleic acids based functionalities.
Computational tools and methods
The Production and assembly
Once a functional RNA nanoparticle has been designed using either strategy, it can be easily produced in vitro through RNA's native self-assembling properties; however, as each strategy relies on different assembly principles their respective approaches to nanoparticle production present different challenges. RNA molecules for assembly can be purchased directly, however current technologies limit the length of RNAs available through commercial synthesis to strands shorter than approximately 80 nucleotides. This is a particular challenge for nanoparticles designed via RNA architectonics because they rely on predefined motifs which are often greater than 100 nts in length, which may be further complicated for nanoparticles designed using either strategy, as the functionalization of a nanoparticle typically involves the addition of relevant sequences to individual strands. An alternative approach is to transcribe RNA strands using T7 RNA polymerase with purchased PCRamplified DNA templates, as DNA templates can be produced Further, nanoparticles may require additional modifications to the underlying structure based on the conditions of the application for which they are being designed, to improve yields, stability, kinetic favorability, as well as allowing the hybridization of functional elements or scaffolds with other nanostructures or devices.
Some examples of RNA nanoscaffold functionalization.
The conjugation of nanoparticles with RNAi inducing agents has seen a substantial increase in interest in the last several years [42, 60, 62, 121, 135] . Briefly, RNA interference, or RNAi, is a process by which the expression of a gene can be silenced through the introduction of a double-stranded RNA (dsRNA).
This dsRNA can be processed by the endonuclease Dicer into a short (21-23 nt) duplex known as short interfering RNAs (siRNAs), which is then loaded into the RNA induced silencing complex (RISC). Half of the duplex, the antisense or guide strand, is used by RISC to selectively cleave a target mRNA, while the sense or passenger strand will be discarded [57] . With the proper choice of a target, a short RNA can be designed to post-transcriptionally silence the expression of any gene. There are a variety of different dsRNAs that can activate RISC each of which have their own properties [60, 136] . The most commonly used are 21-mer siRNAs. However, the functionalization of RNAi-inducing RNA-based NP can be done using elongated siRNA duplexes, so-called "dicer substrates" [137] . Using dicer substrates will allow the siRNAs to be released inside the cell through the process of dicing. Multiple siRNAs for combinatorial RNA interference [138, 139] can be co-delivered together using the RNA NP approach [106] . RNAi has its own set of challenges to implementation which are discussed extensively elsewhere [62] . An example of this is RNAi saturation, in which induction of RNAi with introduced agents can up-regulate the RNAi for hundreds of non-targeted genes; this is distinct from the broader challenges of stability, biodistribution, toxicity, etc, which effect RNA nanomedicine and nanomedicine in general, but is conversely representative of the way in which any specific nanodesign which utilizes existing mechanisms must also address the challenges facing that system as well. Nonetheless, However, the detailed molecular mechanism of co-transcritonal folding of the RNA NP and the factors affecting efficiency of this process remain to be determined.
Functionalization and modification
The scaffolds generated using these complementary design strategies have the capacity to be easily tuned for functionalization in new applications for nanomedicine and synthetic biology because of RNA's characteristic structure, programmability, controllable chemical and thermal stabilities, sequence flexibility, rich tertiary structure, and self-assembly [106] . While some of these applications, such as patterned superstructures for metallic nanoparticle distribution [108] [58, 103] , for example, and the difference in particle size provides some protection from renal filtration, which primarily affects molecules less than 10nm across [109] .
Circularization of a nanoparticle, or the sequestering of 3'-and 5'-ends within the larger structure, is another option that provides protection against ribouncleases [103, 147] , but by far the most applied strategy is the modification of the 2' hydroxyl group of the ribose of individual nucleotides in the RNA strand [60] . This modification provides powerful protection against Figure 5 ) [148] . These hybrids contain the nanoparticle itself, or other devices in a circuit or system; for example a self-cleaving ribozyme coupled with an aptamer could conditionally activate a nanoparticle through allosteric induction [141] . This latter function is of particular note as the RNA nanoparticle's characteristic capacity for multivalency readily recommends it for the engineering of complex behaviors. Such a "smart" particle could overcome challenges of localization, concentration, and other limitations where independently acting functional units are non-ideal or prohibitive.
In a related approach with promise for engineering "smart" nanodevices, nanoparticles can be functionalized with aptamers for high-efficiency cell sorting, and to achieve imaging or therapeutic delivery to targets flexibly and specifically [85] .
Aptamers are oligonucleotides with well-defined tertiary structure that bind specific ligands, which can be used to target disease relevant markers [142] [143] [144] . Randomized RNA pools are screened via Systematic Evolution of Ligands EXponential enrichment (SELEX) to select aptamers for a given target.
Aptamers have been concatenated with RNA NP for targeted cancer cells in preliminary studies [20] and tracking of RNA NP assembly [104] , as well as hybridized with siRNA [142] for targeted silencing in cancer cells. While the potential use of functional RNA assemblies as packaging and delivery vehicles of therapeutic RNAs is presently in progress, the limitations in production of RNA nanostructures is immediately apparent through comparison to some naturally occurring RNA structures. At the moment, it is impossible to design RNA NPs with the size and functional complexity such as the ribosome, spliceosome and the pRNA motor of bacteriophage Phi29. These structures are far from discouraging, however; rather they provide a frame of reference with which to gauge the capacities of RNA as a platform. The ribosome can be used to demarcate a rough boundary line in terms of size and complexity. The bacteriophage Phi29 pRNA has proven that complex RNA structures can be redesigned for numerous uses, and suggests a future for more advanced RNA nanodevices and techniques. Similarly, the assembly strategy hypothesized for DsrA in bacteria, which is extremely similar to that of single stranded tile assembly, shows that the application of nucleic acid nanoscaffolds naturally extends in vivo.
While the vast majority of nucleic acid nanodevices are to date limited to in vitro and in vivo applications, this is changing. 
